“…Hippocampal neurons have receptors for melatonin (Morgan et al, 1994;Musshoff et al, 2002), and the administration of this hormone is known to alter excitability and synaptic transmission within the hippocampus (Hogan et al, 2001;Musshoff et al, 2002;Wan et al, 1999), and melatonin has been shown to alter hippocampal synaptic plasticity through the MT2-mediated regulation of the adenylate cyclase-protein kinase A (AC-PKA) pathway (Wang et al, 2005). The synaptic plasticity in the hippocampus and other brain regions has recently gained attention as an important means by which melatonin may augment its neuroprotective effects beyond reductions in oxidative stress alone (Baydas et al, 2005;Bob and Fedor-Freybergh, 2008;Fukunaga et al, 2002;Gorfine and Zisapel, 2007;Larson et al, 2006;Talaei et al, 2009;Wang et al, 2005). In light of these findings, and those of this study, there is an urgent need for more high-quality mechanistic studies to further investigate these plasticity processes as a possible means of improving outcomes after ICH.…”